Biote Analyst Price Targets - Benzinga

Biote Corp

BTMDNASDAQ

Trade with Public

Trade with Public

$1.16

0.1211.54%

Ult. Agg.: Oct 14, 1:34 PM

$1.09

0.054.81%

Panoramica Notizie Previsioni utiliObiettivi di prezzoDati finanziari Sentiment Azionariato Confronta Rapporto azionario

Biote Analyst Price Targets

Wall Street analyst price targets and consensus rating for Biote (BTMD).

Price Target Range — 7 Quarters

Analyst Consensus — 6 Analysts

5Buy

1Hold

Consensus RatingBuy# Analysts6Avg. Consensus PT$5Upside to Avg. PT+345.7%

Rating Trend — Last 9 Months

Recent Analyst Actions

Visualizza tutte le valutazioni →

Date	Firm	Analyst	Action	Rating Change	Price Target
Aug 10, 2026	B. Riley Securities	Jeff Van Sinderen	PT Cut	Neutral	$2→$2
Aug 7, 2026	TD Cowen	Jonna Kim	PT Cut	Buy	$3→$2
Apr 16, 2026	Truist Securities	Gregory Fraser	PT Cut	Buy	$5→$4
Mar 12, 2026	B. Riley Securities	Jeff Van Sinderen	PT Cut	Neutral	$3→$2
Mar 12, 2026	TD Cowen	Jonna Kim	PT Cut	Buy	$3→$3
Aug 7, 2025	B. Riley Securities	Jeff Van Sinderen	Downgrade	Buy→Neutral	$8→$4
Mar 13, 2025	Craig-Hallum	Alex Fuhrman	PT Cut	Buy	$12→$8
Dec 16, 2024	Craig-Hallum	Alex Fuhrman	Initiate	Buy	$12
Mar 13, 2024	Roth MKM	George Kelly	PT Raise	Buy	$8→$9
Feb 20, 2024	B. Riley Securities	Jeff Van Sinderen	Initiate	Buy	$9
Feb 1, 2024	Jefferies	Kaumil Gajrawala	Initiate	Buy	$7
Jan 18, 2024	Truist Securities	Gregory Fraser	PT Cut	Buy	$10→$9
Jan 18, 2024	Roth MKM	George Kelly	PT Cut	Buy	$8→$7

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
B. Riley Securities Maintains Neutral on Biote, Lowers Price Target to $1.5

B. Riley Securities analyst Jeff Van Sinderen maintains Biote (NASDAQ:BTMD) with a Neutral and lowers the price target from $2 to $1.5.

Benzinga Newsdesk

PRO
TD Cowen Maintains Buy on Biote, Lowers Price Target to $2

TD Cowen analyst Jonna Kim maintains Biote (NASDAQ:BTMD) with a Buy and lowers the price target from $2.5 to $2.

Benzinga Newsdesk

PRO
Truist Securities Maintains Buy on Biote, Lowers Price Target to $4

Truist Securities analyst Gregory Fraser maintains Biote (NASDAQ:BTMD) with a Buy and lowers the price target from $5 to $4.

Benzinga Newsdesk

PRO
B. Riley Securities Maintains Neutral on Biote, Lowers Price Target to $2

B. Riley Securities analyst Jeff Van Sinderen maintains Biote (NASDAQ:BTMD) with a Neutral and lowers the price target from $3 to $2.

Benzinga Newsdesk

PRO
TD Cowen Maintains Buy on Biote, Lowers Price Target to $2.5

TD Cowen analyst Jonna Kim maintains Biote (NASDAQ:BTMD) with a Buy and lowers the price target from $3 to $2.5.

Benzinga Newsdesk

PRO
B. Riley Securities Downgrades Biote to Neutral, Lowers Price Target to $4

B. Riley Securities analyst Jeff Van Sinderen downgrades Biote (NASDAQ:BTMD) from Buy to Neutral and lowers the price target from $8 to $4.

Benzinga Newsdesk